This Company Wants to Cure Pancreatic Cancer Using AI

Four people stand, eyes squinting, on the verdant, freshly mowed field of Boston’s Fenway Park. It’s a blue-sky summer day, a perfect afternoon for a baseball game. The smiles on their faces are broad, if a bit shy. They are among the lucky ones—the tiny share of people who fought and survived ­pancreatic cancer. The scene is from a photograph pinned to a cubicle at Beth Israel Deaconess Medical Center in Boston. “What is it about these four people on the field?” asks James Moser, executive director of the Institute for Hepatobiliary and Pancreatic Surgery at Beth Israel. “Each one of them is sort of their own miracle.” Berg, a biotech startup in nearby Framingham, Mass., is working with Moser and other researchers to find out why. Pancreatic cancer is…


Link to Full Article: This Company Wants to Cure Pancreatic Cancer Using AI